Sina Hamzehzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sina Hamzehzadeh has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Amirreza Naseri
Student Research Committee Tabriz University of Medical Sciences Tabriz Iran
11 shared publications - Erfan Banisefid
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
7 shared publications - Mohammad-Salar Hosseini
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6 shared publications - Hanieh Salehi-Pourmehr
Tabriz University of Medical Sciences
5 shared publications - Elnaz Javanshir
Cardiovascular Research Center, Shahid Madani Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
4 shared publications - Mahnaz Talebi
Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran
4 shared publications
Latest Publications
- 16 October 2026
- Published by Wiley in Neurourology and Urodynamics
Management of Urinary Symptoms in Multiple Sclerosis: An Umbrella Review
Background: Lower urinary tract dysfunctions (LUTDs) are prevalent among patients with multiple sclerosis (MS), which is the most common immune‐mediated neurologic disease among the juvenile population. This study aims to evaluate the efficacy and safety of different methods in the management of MS‐related LUTD. Methods: This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement and Joanna Briggs Institute (JBI) methods. Systematic review studies that reported the efficacy of any management method for LUTD in MS are considered for inclusion. A systematic search was conducted in PubMed, Scopus, Embase, and Web of Science and risk of bias was assessed using the JBI critical appraisal checklist for systematic reviews. Results: Out of 342 screened records, 34 systematic reviews were included. Preliminary efficacy and safety of pelvic floor muscle training (PFMT) and tibial nerve stimulation (TNS), as well as the potential of alpha‐blockers, cannabinoids, mirabegron, spinal cord stimulation, sacral neuromodulation, transcranial neuromodulations, vaginal/rectal and clitoral/penile stimulation, foot reflexology, craniosacral therapy, and stem cell therapy were suggested. Despite the appropriate efficacy, anticholinergics, desmopressin, intradetrusor injections of botulinum toxin A, vanilloids, and catheterization were found to cause considerable side effects. Discussion: Despite a high prevalence of LUTDs in MS patients, evidence basis of the management methods is still poor and there is lack of well‐designed randomized controlled trials, which makes evidence inconclusive. Future research is needed to refine treatment algorithms, investigate the potential of combination therapies, and develop individualized treatment paradigms.
- 16 October 2026
- Published by Wiley in Neurourology and Urodynamics
Management of Urinary Symptoms in Multiple Sclerosis: An Umbrella Review
Background: Lower urinary tract dysfunctions (LUTDs) are prevalent among patients with multiple sclerosis (MS), which is the most common immune‐mediated neurologic disease among the juvenile population. This study aims to evaluate the efficacy and safety of different methods in the management of MS‐related LUTD. Methods: This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement and Joanna Briggs Institute (JBI) methods. Systematic review studies that reported the efficacy of any management method for LUTD in MS are considered for inclusion. A systematic search was conducted in PubMed, Scopus, Embase, and Web of Science and risk of bias was assessed using the JBI critical appraisal checklist for systematic reviews. Results: Out of 342 screened records, 34 systematic reviews were included. Preliminary efficacy and safety of pelvic floor muscle training (PFMT) and tibial nerve stimulation (TNS), as well as the potential of alpha‐blockers, cannabinoids, mirabegron, spinal cord stimulation, sacral neuromodulation, transcranial neuromodulations, vaginal/rectal and clitoral/penile stimulation, foot reflexology, craniosacral therapy, and stem cell therapy were suggested. Despite the appropriate efficacy, anticholinergics, desmopressin, intradetrusor injections of botulinum toxin A, vanilloids, and catheterization were found to cause considerable side effects. Discussion: Despite a high prevalence of LUTDs in MS patients, evidence basis of the management methods is still poor and there is lack of well‐designed randomized controlled trials, which makes evidence inconclusive. Future research is needed to refine treatment algorithms, investigate the potential of combination therapies, and develop individualized treatment paradigms.
- 1 October 2026
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 7 (5) , 1-12
Infantile COVID-19: An Evidence-based and Updated Narrative Review
Infantile COVID-19, caused by SARS-CoV-2, presents unique challenges in diagnosis, management, and outcomes compared to adults. Due to their physiological limits, infants, defined as children under one year old, are categorized among vulnerable health groups, highlighting the importance of effective and timely prevention, diagnosis, and treatment. This review provides the latest evidence on the epidemiology, prevention, clinical diagnosis, and treatment of COVID-19 infection in infants, discussing the existing controversies and highlighting current knowledge gaps. An extensive literature search was performed in MEDLINE (via PubMed), Web of Science, and Scopus databases with relevant free keywords and MeSH terms to identify related records without any restrictions in time or language. Generally exhibiting nonspecific symptoms, COVID-19 can overlap with common respiratory infections among infants. Moreover, the lack of effective verbal communication in infants complicates the symptom assessment, turning the timely diagnosis into a difficult challenge for healthcare providers. Additionally, maternal transmission of SARS-CoV-2 during pregnancy, childbirth, or postpartum care also raises concerns about neonatal infection, with potential implications for both maternal and infant health. Several agents have been proposed for the treatment of infantile COVID-19, including glucocorticoids, intravenous immunoglobulin, tocilizumab, and antivirals such as remdesivir, ritonavir, and favipiravir. Current evidence supports the potential effectiveness of extracorporeal membrane oxygenation and nutrition supplements; however, their ultimate effectiveness is still controversial. As an effective preventive strategy, more studies are required to determine the safety and efficacy of vaccination in this population. The complexity of diagnostic and clinical management associated with COVID-19 poses serious challenges for this group of patients. In managing infantile COVID-19, supportive care is still critical, emphasizing good nutritional support, efficient oxygenation, and hemodynamic maintenance. Given the limited available evidence on immunomodulators, antiviral medications, and other pharmaceutical interventions in this population, safety and efficacy profiles must be carefully considered. Future research should focus on the effectiveness of vaccination, the safety of the currently proposed treatments, and the long-term consequences of COVID-19 infection.
- 1 October 2026
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 7 (5) , 1-12
Infantile COVID-19: An Evidence-based and Updated Narrative Review
Infantile COVID-19, caused by SARS-CoV-2, presents unique challenges in diagnosis, management, and outcomes compared to adults. Due to their physiological limits, infants, defined as children under one year old, are categorized among vulnerable health groups, highlighting the importance of effective and timely prevention, diagnosis, and treatment. This review provides the latest evidence on the epidemiology, prevention, clinical diagnosis, and treatment of COVID-19 infection in infants, discussing the existing controversies and highlighting current knowledge gaps. An extensive literature search was performed in MEDLINE (via PubMed), Web of Science, and Scopus databases with relevant free keywords and MeSH terms to identify related records without any restrictions in time or language. Generally exhibiting nonspecific symptoms, COVID-19 can overlap with common respiratory infections among infants. Moreover, the lack of effective verbal communication in infants complicates the symptom assessment, turning the timely diagnosis into a difficult challenge for healthcare providers. Additionally, maternal transmission of SARS-CoV-2 during pregnancy, childbirth, or postpartum care also raises concerns about neonatal infection, with potential implications for both maternal and infant health. Several agents have been proposed for the treatment of infantile COVID-19, including glucocorticoids, intravenous immunoglobulin, tocilizumab, and antivirals such as remdesivir, ritonavir, and favipiravir. Current evidence supports the potential effectiveness of extracorporeal membrane oxygenation and nutrition supplements; however, their ultimate effectiveness is still controversial. As an effective preventive strategy, more studies are required to determine the safety and efficacy of vaccination in this population. The complexity of diagnostic and clinical management associated with COVID-19 poses serious challenges for this group of patients. In managing infantile COVID-19, supportive care is still critical, emphasizing good nutritional support, efficient oxygenation, and hemodynamic maintenance. Given the limited available evidence on immunomodulators, antiviral medications, and other pharmaceutical interventions in this population, safety and efficacy profiles must be carefully considered. Future research should focus on the effectiveness of vaccination, the safety of the currently proposed treatments, and the long-term consequences of COVID-19 infection.
- Open Access
- 8 July 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e2590873
The Association Between Serum α‐Tocopherol and Pathogenesis of Multiple Sclerosis: A Systematic Review and Meta‐Analysis of Case‐Control Studies
Oxidative stress is a key pathological mechanism of multiple sclerosis (MS) and α‐tocopherol is recognized as a primary chain‐breaking antioxidant. This study is aimed at investigating the relationship between serum α‐tocopherol and the pathogenesis of MS This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement and the Joanna Briggs Institute (JBI) manual for evidence synthesis. Scopus, PubMed, Web of Science, and Embase were searched in March 2025. The risk of bias was evaluated using the critical appraisal tool developed by JBI. All statistical analyses were performed with comprehensive meta‐analysis software (CMA3). Out of 506 records evaluated during the title/abstract screening phase, five case‐control studies were included. Studies encompassed a total of 389 participants, comprising 211 individuals diagnosed with MS and 178 healthy controls. The levels of α‐tocopherol were found to be lower in MS patients compared to the healthy group (standardized mean difference [SMD] = −1.17; 95% CI: −2.02, −0.31; p = 0.007, I 2 = 91.5%, p < 0.001; predictive values: −3.13, 0.79). Although subgroup analyses were performed based on sample size, sex, and phase of the diseases, the source of heterogeneity was not found. Current evidence supports the possible association of serum α‐tocopherol and MS pathogenesis; however, considering the restricted number of included studies (five papers), the retrospective nature of the studies, and substantial heterogeneity in the conducted quantitative synthesis, multicenter and large‐scale prospective studies are recommended.
- 8 July 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e2590873
Open AccessThe Association Between Serum α‐Tocopherol and Pathogenesis of Multiple Sclerosis: A Systematic Review and Meta‐Analysis of Case‐Control Studies
Oxidative stress is a key pathological mechanism of multiple sclerosis (MS) and α‐tocopherol is recognized as a primary chain‐breaking antioxidant. This study is aimed at investigating the relationship between serum α‐tocopherol and the pathogenesis of MS This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement and the Joanna Briggs Institute (JBI) manual for evidence synthesis. Scopus, PubMed, Web of Science, and Embase were searched in March 2025. The risk of bias was evaluated using the critical appraisal tool developed by JBI. All statistical analyses were performed with comprehensive meta‐analysis software (CMA3). Out of 506 records evaluated during the title/abstract screening phase, five case‐control studies were included. Studies encompassed a total of 389 participants, comprising 211 individuals diagnosed with MS and 178 healthy controls. The levels of α‐tocopherol were found to be lower in MS patients compared to the healthy group (standardized mean difference [SMD] = −1.17; 95% CI: −2.02, −0.31; p = 0.007, I 2 = 91.5%, p < 0.001; predictive values: −3.13, 0.79). Although subgroup analyses were performed based on sample size, sex, and phase of the diseases, the source of heterogeneity was not found. Current evidence supports the possible association of serum α‐tocopherol and MS pathogenesis; however, considering the restricted number of included studies (five papers), the retrospective nature of the studies, and substantial heterogeneity in the conducted quantitative synthesis, multicenter and large‐scale prospective studies are recommended.
- Open Access
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Sarcoid Nodular Myopathy Presenting With Hypercalcemia: A Rare Presentation—Case Report
An 18‐year‐old female patient with no past medical history presented with nonanginal chest pain 2 months after her delivery. She did not report any other symptoms such as cough, dyspnea, nausea, or vomiting. Her vital signs were stable. The only positive finding on physical examination was tenderness and edema, with a palpable lump on her right thigh. Other examinations did not provide any additional information. Her lab results showed elevated calcium (12.5 mg/dL), low parathyroid hormone (5.6 pg/mL), and near‐normal 25‐(OH) Vitamin D levels (27.4 ng/dL). The core needle biopsy of the right thigh muscle revealed patchy lymphocytic infiltration with giant cells, without caseous necrosis, suggestive of sarcoidosis. The patient also had elevated angiotensin‐converting enzyme levels. The computed tomography of the lungs revealed no pulmonary involvement or hilar lymphadenopathy. The patient was treated with 30 mg of prednisolone daily. One month later, her symptoms improved, and calcium levels returned to normal.
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Open AccessSarcoid Nodular Myopathy Presenting With Hypercalcemia: A Rare Presentation—Case Report
An 18‐year‐old female patient with no past medical history presented with nonanginal chest pain 2 months after her delivery. She did not report any other symptoms such as cough, dyspnea, nausea, or vomiting. Her vital signs were stable. The only positive finding on physical examination was tenderness and edema, with a palpable lump on her right thigh. Other examinations did not provide any additional information. Her lab results showed elevated calcium (12.5 mg/dL), low parathyroid hormone (5.6 pg/mL), and near‐normal 25‐(OH) Vitamin D levels (27.4 ng/dL). The core needle biopsy of the right thigh muscle revealed patchy lymphocytic infiltration with giant cells, without caseous necrosis, suggestive of sarcoidosis. The patient also had elevated angiotensin‐converting enzyme levels. The computed tomography of the lungs revealed no pulmonary involvement or hilar lymphadenopathy. The patient was treated with 30 mg of prednisolone daily. One month later, her symptoms improved, and calcium levels returned to normal.
- Open Access
- 28 January 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer
Lung cancer ranks as the second most prevalent cancer worldwide and exhibits the highest mortality rate among all cancers. It primarily consists of two subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with NSCLC representing 80–85% of cases. The Wnt/β-catenin signaling pathway is crucial in lung cancer initiation, progression, metastasis, and chemoresistance. MicroRNAs (miRNAs), small non-coding RNAs, significantly influence the tumor microenvironment by modulating cancer cell proliferation, angiogenesis, and apoptosis through the targeting of specific genes. Depending on their targets, miRNAs can function as oncogenes or tumor suppressors, highlighting their potential as therapeutic targets. Additionally, miRNAs serve as novel biomarkers for cancer diagnosis. Understanding the key miRNAs involved in lung cancer and their interactions with pathways like Wnt is essential for developing new diagnostic and therapeutic approaches. This review focuses on how specific miRNAs affect the Wnt pathway's components and their roles in tumorigenesis, metastasis, and therapy resistance, emphasizing their potential as therapeutic targets in NSCLC. Ultimately, this review aims to improve clinical outcomes and facilitate personalized therapeutic approaches for this aggressive malignancy. Graphical Abstract
- 28 January 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Open AccessThe role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer
Lung cancer ranks as the second most prevalent cancer worldwide and exhibits the highest mortality rate among all cancers. It primarily consists of two subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with NSCLC representing 80–85% of cases. The Wnt/β-catenin signaling pathway is crucial in lung cancer initiation, progression, metastasis, and chemoresistance. MicroRNAs (miRNAs), small non-coding RNAs, significantly influence the tumor microenvironment by modulating cancer cell proliferation, angiogenesis, and apoptosis through the targeting of specific genes. Depending on their targets, miRNAs can function as oncogenes or tumor suppressors, highlighting their potential as therapeutic targets. Additionally, miRNAs serve as novel biomarkers for cancer diagnosis. Understanding the key miRNAs involved in lung cancer and their interactions with pathways like Wnt is essential for developing new diagnostic and therapeutic approaches. This review focuses on how specific miRNAs affect the Wnt pathway's components and their roles in tumorigenesis, metastasis, and therapy resistance, emphasizing their potential as therapeutic targets in NSCLC. Ultimately, this review aims to improve clinical outcomes and facilitate personalized therapeutic approaches for this aggressive malignancy. Graphical Abstract
- Open Access
- 6 January 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Polymorphisms in CLOCK and ARNTL/BMAL-1 genes in multiple sclerosis: a systematic review and meta-analysis
Multiple sclerosis (MS) is still under investigation for its pathogenesis. This study explores the relationship between the key circadian rhythm regulators
- 6 January 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Open AccessPolymorphisms in CLOCK and ARNTL/BMAL-1 genes in multiple sclerosis: a systematic review and meta-analysis
Multiple sclerosis (MS) is still under investigation for its pathogenesis. This study explores the relationship between the key circadian rhythm regulators
- Open Access
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1)
Air Pollution and Parkinson’s Disease Pathology: Clinical Evidence and the Molecular Mechanisms Linking Airborne Toxicants to Neuroinflammation and Neurodegeneration
Parkinson’s disease (PD) is a neurodegenerative condition, and its rising prevalence necessitates the urgent need to identify modifiable risk factors. Air pollution, a pervasive and also escalating public health problem, has emerged as a potential contributor to the incidence and progression of PD. As urbanization and industrialization continue to exacerbate global air pollution levels, understanding the relationship between airborne toxicants and PD is a pressing scientific and public health priority. In this review, we critically discuss the current epidemiological evidence and the cellular and molecular mechanisms underlying air pollution‐induced neurodegeneration in PD. Clinical studies associate long‐term interaction with pollutants such as nitrogen oxides, particulate matter, and ozone with increased PD risk. Evidence also suggests that air pollution worsens PD prognosis. Mechanistically, air pollution is hypothesized to contribute to PD pathogenesis through gut microbiome alternations, oxidative stress, and neuroinflammatory pathways, as well as promoting α‐synuclein aggregation.
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1)
Open AccessAir Pollution and Parkinson’s Disease Pathology: Clinical Evidence and the Molecular Mechanisms Linking Airborne Toxicants to Neuroinflammation and Neurodegeneration
Parkinson’s disease (PD) is a neurodegenerative condition, and its rising prevalence necessitates the urgent need to identify modifiable risk factors. Air pollution, a pervasive and also escalating public health problem, has emerged as a potential contributor to the incidence and progression of PD. As urbanization and industrialization continue to exacerbate global air pollution levels, understanding the relationship between airborne toxicants and PD is a pressing scientific and public health priority. In this review, we critically discuss the current epidemiological evidence and the cellular and molecular mechanisms underlying air pollution‐induced neurodegeneration in PD. Clinical studies associate long‐term interaction with pollutants such as nitrogen oxides, particulate matter, and ozone with increased PD risk. Evidence also suggests that air pollution worsens PD prognosis. Mechanistically, air pollution is hypothesized to contribute to PD pathogenesis through gut microbiome alternations, oxidative stress, and neuroinflammatory pathways, as well as promoting α‐synuclein aggregation.
- Open Access
- 31 December 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 37 (1)
An overview of types of antibacterial coatings and methods for creating them on orthodontic wires
Orthodontic therapy utilizing fixed equipment frequently results in heightened plaque accumulation, which can cause enamel demineralization and periodontal issues. Recent breakthroughs in surface coating technology have brought various antimicrobial techniques designed to diminish bacterial adherence and biofilm formation on orthodontic components. This study thoroughly examines many types of antibacterial coatings, including metallic nanoparticles (such as silver, zinc, and titanium), polymeric layers, carbon-based materials, and bioactive chemicals, emphasizing their modes of action, microbial targets, and therapeutic significance. Silver-based coatings are among the most thoroughly researched due to their continuous ion release and broad-spectrum antibacterial effectiveness. Photocatalytic titanium dioxide and synergistic composite coatings demonstrate promising outcomes under particular activation conditions. The review examines biocompatibility concerns, long-term durability, and the limitations of existing methodologies, while suggesting future research avenues to connect laboratory innovations with clinical applications. The surface modification of orthodontic equipment offers a practical approach to reducing oral health hazards associated with therapy and improving patient outcomes. Graphical Abstract
- 31 December 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 37 (1)
Open AccessAn overview of types of antibacterial coatings and methods for creating them on orthodontic wires
Orthodontic therapy utilizing fixed equipment frequently results in heightened plaque accumulation, which can cause enamel demineralization and periodontal issues. Recent breakthroughs in surface coating technology have brought various antimicrobial techniques designed to diminish bacterial adherence and biofilm formation on orthodontic components. This study thoroughly examines many types of antibacterial coatings, including metallic nanoparticles (such as silver, zinc, and titanium), polymeric layers, carbon-based materials, and bioactive chemicals, emphasizing their modes of action, microbial targets, and therapeutic significance. Silver-based coatings are among the most thoroughly researched due to their continuous ion release and broad-spectrum antibacterial effectiveness. Photocatalytic titanium dioxide and synergistic composite coatings demonstrate promising outcomes under particular activation conditions. The review examines biocompatibility concerns, long-term durability, and the limitations of existing methodologies, while suggesting future research avenues to connect laboratory innovations with clinical applications. The surface modification of orthodontic equipment offers a practical approach to reducing oral health hazards associated with therapy and improving patient outcomes. Graphical Abstract
- Open Access
- 15 October 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-12
Serum markers and gastric cancer: an umbrella review
Early detection of gastric cancer (GC) is crucial for lowering the mortality risk and health burden. Since various biomarkers have been studied for the early diagnosis of GC, this umbrella focuses on the serum markers valuable in GC, for whether detecting or predicting the risk. Following the PRISMA statement and Joanna Briggs Institute (JBI) Manual, PubMed, Scopus, and Web of Science were searched before August 31, 2023. English-language systematic reviews that assessed the association between serum markers and the presence of and/or predicting the risk of GC with or without meta-analyses were included in this umbrella review. The chosen reviews assessed serum markers in GC, and the quality assessment was conducted by the JBI critical appraisal tool for systematic reviews. From 1441 records that remained after removing the duplicates, only seven were selected. The investigated serum markers in the studies included SOD activity, selenium, adiponectin dickkopf-1, pepsinogens, and autoantibodies. The bias risk in most of the included reviews was appropriately low. Overall, the SOD activity, circulating adiponectin, and selenium are suggested to be lower in patients with GC. Serum dickkopf-1 and serum pepsinogen are also proposed as potential biomarkers for GC. Considering the great heterogeneity between the studies, the possibility of publication bias, and the limited number of the included studies further investigation is required. The explained serum biomarkers could be helpful for diagnosis and predicting GC; however, further well-designed large-scale investigation is needed to ensure their clinical applications.
- 15 October 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-12
Open AccessSerum markers and gastric cancer: an umbrella review
Early detection of gastric cancer (GC) is crucial for lowering the mortality risk and health burden. Since various biomarkers have been studied for the early diagnosis of GC, this umbrella focuses on the serum markers valuable in GC, for whether detecting or predicting the risk. Following the PRISMA statement and Joanna Briggs Institute (JBI) Manual, PubMed, Scopus, and Web of Science were searched before August 31, 2023. English-language systematic reviews that assessed the association between serum markers and the presence of and/or predicting the risk of GC with or without meta-analyses were included in this umbrella review. The chosen reviews assessed serum markers in GC, and the quality assessment was conducted by the JBI critical appraisal tool for systematic reviews. From 1441 records that remained after removing the duplicates, only seven were selected. The investigated serum markers in the studies included SOD activity, selenium, adiponectin dickkopf-1, pepsinogens, and autoantibodies. The bias risk in most of the included reviews was appropriately low. Overall, the SOD activity, circulating adiponectin, and selenium are suggested to be lower in patients with GC. Serum dickkopf-1 and serum pepsinogen are also proposed as potential biomarkers for GC. Considering the great heterogeneity between the studies, the possibility of publication bias, and the limited number of the included studies further investigation is required. The explained serum biomarkers could be helpful for diagnosis and predicting GC; however, further well-designed large-scale investigation is needed to ensure their clinical applications.
- Open Access
- 25 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Association of serum trace elements with non-invasive fibrosis scores in metabolic dysfunction-associated steatotic liver disease
Liver biopsy is not a routine screening tool for detecting fibrosis progression in metabolic dysfunction-associated steatotic liver disease (MASLD). Noninvasive methods based on serum biomarkers are used instead. This study evaluated the relationship between serum zinc (Zn), copper (Cu), and ceruloplasmin levels and non-invasive criteria for hepatic fibrosis, including Fibrosis-4 (FIB-4), Nonalcoholic Fatty Liver Disease fibrosis score (NFS), and BARD, in patients with MASLD. In this prospective cross-sectional study, a total of 134 MASLD patients referred to the gastroenterology clinic of Imam Reza Hospital and Sheikh AlRaees Clinic, Tabriz, in 2022 were included. Serum levels of Zn, Cu, ceruloplasmin, albumin, complete blood count (CBC), fasting blood sugar (FBS), Alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were checked. Also, non-invasive measures of FIB-4, NFS, and BARD were measured. Finally, the relationship between the levels of Zn, Cu, and ceruloplasmin with each of the FIB-4, NFS, and BARD criteria was investigated. Zn serum levels were significantly lower in FIB-4 3 than in FIB-4 1 and 2 (P-value < 0.01); however, no significant relationship was found between serum Cu and ceruloplasmin variables with FIB-4 (P > 0.05). Zn serum levels were also significantly higher in NFS fibrosis score 1 (P-value < 0.01). There was no significant relationship between serum Cu and ceruloplasmin variables with NFS fibrosis score in the studied patients (P > 0.05). No significant relationship was observed between serum Zn, Cu, and ceruloplasmin with the BARD fibrosis score in the studied patients (P > 0.05). It seems that among the levels of Zn, Cu, and ceruloplasmin serum with non-invasive measures of liver fibrosis, including FIB-4, NFS, and BARD in MASLD patients, there is only a significant relationship between serum Zn level and FIB-4 and NFS criteria. And therefore, Zn may serve as a potential biomarker.
- 25 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Open AccessAssociation of serum trace elements with non-invasive fibrosis scores in metabolic dysfunction-associated steatotic liver disease
Liver biopsy is not a routine screening tool for detecting fibrosis progression in metabolic dysfunction-associated steatotic liver disease (MASLD). Noninvasive methods based on serum biomarkers are used instead. This study evaluated the relationship between serum zinc (Zn), copper (Cu), and ceruloplasmin levels and non-invasive criteria for hepatic fibrosis, including Fibrosis-4 (FIB-4), Nonalcoholic Fatty Liver Disease fibrosis score (NFS), and BARD, in patients with MASLD. In this prospective cross-sectional study, a total of 134 MASLD patients referred to the gastroenterology clinic of Imam Reza Hospital and Sheikh AlRaees Clinic, Tabriz, in 2022 were included. Serum levels of Zn, Cu, ceruloplasmin, albumin, complete blood count (CBC), fasting blood sugar (FBS), Alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were checked. Also, non-invasive measures of FIB-4, NFS, and BARD were measured. Finally, the relationship between the levels of Zn, Cu, and ceruloplasmin with each of the FIB-4, NFS, and BARD criteria was investigated. Zn serum levels were significantly lower in FIB-4 3 than in FIB-4 1 and 2 (P-value < 0.01); however, no significant relationship was found between serum Cu and ceruloplasmin variables with FIB-4 (P > 0.05). Zn serum levels were also significantly higher in NFS fibrosis score 1 (P-value < 0.01). There was no significant relationship between serum Cu and ceruloplasmin variables with NFS fibrosis score in the studied patients (P > 0.05). No significant relationship was observed between serum Zn, Cu, and ceruloplasmin with the BARD fibrosis score in the studied patients (P > 0.05). It seems that among the levels of Zn, Cu, and ceruloplasmin serum with non-invasive measures of liver fibrosis, including FIB-4, NFS, and BARD in MASLD patients, there is only a significant relationship between serum Zn level and FIB-4 and NFS criteria. And therefore, Zn may serve as a potential biomarker.